PharmaFrontiers Appoints Gregory Bailey, M.D. And Scott Seaman, CPA, To Board Of Directors

THE WOODLANDS, Texas--(BUSINESS WIRE)--April 17, 2006--PharmaFrontiers Corp. (OTCBB:PFTR - News), a company involved in the development and commercialization of cell therapies, today announced the appointment of Gregory H. Bailey, M.D., and Scott B. Seaman, CPA and CFP, to PharmaFrontiers' board of directors. The Company also announced that Brooks Boveroux, Tony Kamin and Terry Wesner have stepped down from their positions on the board in connection with the closing of the $23 million financing.